M-A | Comparação da efetividade das estatinas sobre o colesterol não HDL em pessoas com diabetes e risco de doença cardiovascular.
25 Mar, 2022 | 16:17hComunicado de imprensa: Best statins for reducing cardiovascular risk in people with diabetes found – University of Manchester
Comentário no Twitter
This network meta-analysis indicated that rosuvastatin, at moderate and high intensity doses, and simvastatin and atorvastatin, at high intensity doses, were most effective at moderately reducing levels of non-HDL-C in patients with diabeteshttps://t.co/NwUf4sX5KA
— The BMJ (@bmj_latest) March 24, 2022